List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 70 studies with search of:   "Candesartan"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting ARIA(Atacand Renoprotection In NephropAthy Pt.)
Condition: Non-Diabetic Nephropathy With Hypertension
Interventions: Drug: Candesartan Cilexetil;   Drug: Candesartan Cilexetil;   Drug: Candesartan Cilexetil 32mg
2 Active, not recruiting Candesartan Effect in Second Stage Arterial Hypertension
Condition: Stage II Hypertension
Interventions: Drug: Candesartan Cilexetil;   Drug: Hydrochlorothiazide;   Drug: Candesartan Cilexetil
3 Active, not recruiting Atacand Dose Ranging in Hypertensive Pediatric Subjects 1 Year to Less Than 6 Years of Age
Condition: Hypertension
Interventions: Drug: candesartan cilexetil (Atacand);   Drug: candesartan cilexetil (Atacand);   Drug: candesartan cilexetil (Atacand)
4 Recruiting The Potential of Rosuvastatin and Candesartan to Retard the Progression of Aortic Stenosis
Condition: Aortic Valve Stenosis
Interventions: Drug: rosuvastatin;   Drug: candesartan;   Drug: rosuvastatin and candesartan;   Drug: placebo
5 Recruiting A Randomized, Double-Blind, Active Control Trial Comparing Effects of Telmisartan, Candesartan and Amlodipine, Alone or Plus Metformin, on Non-Diabetic, Obese Hypertensive Patients
Conditions: Hypertension;   Obesity
Interventions: Drug: Telmisartan plus Metformin;   Drug: Telmisartan;   Drug: Candesartan;   Drug: Candesartan plus Metformin;   Drug: Amlodipine;   Drug: Amlodipine plus Metformin
6 Completed Candesartan Cilexetil in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM Added)
Condition: Congestive Heart Failure
Interventions: Drug: Candesartan;   Drug: Placebo
7 Completed Candesartan Cilexetil in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM Preserved)
Condition: Congestive Heart Failure
Interventions: Drug: Candesartan;   Drug: Placebo
8 Completed Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM Alternative)
Condition: Congestive Heart Failure
Interventions: Drug: Candesartan;   Drug: Placebo
9 Completed Antihypertensive Efficacy and Safety of Candesartan/HCT 32/12.5 and 32/25 mg in Comparison With Candesartan 32 mg
Condition: Hypertension
Interventions: Drug: Candesartan cilexetil;   Drug: Hydrochlorothiazide;   Drug: Hydrochlorothiazide
10 Completed Atacand (Candesartan) Real Life Study
Condition: Hypertension
Interventions: Drug: Candesartan Cilexetil;   Drug: Losartan
11 Recruiting Pulse Wave Velocity, Pulse Wave Morphology and Blocking of the Reninangiotensin System in Patients With Chronic Kidney Disease
Conditions: Kidney Failure, Chronic;   Cardiovascular Diseases
Interventions: Drug: Candesartan and enalapril;   Drug: candesartan and enalapril;   Drug: candesartan and enalapril;   Drug: candesartan and enalapril
12 Recruiting Observational Usage and Efficacy Study of Candesartan in Heart Failure Treatment in France
Conditions: Heart Failure;   Cohort Study
Intervention: Drug: Candesartan
13 Completed Efficacy of Candesartan on Reducing Blood Pressure in Insulin-Resistant, Obese Patients With Hypertension.
Conditions: Obesity;   Hypertension
Interventions: Drug: Candesartan and hydrochlorothiazide;   Drug: Hydrochlorothiazide
14 Completed Antihypertensive Efficacy and Safety of Candesartan/HCT 32/25 mg in Comparison With Individual Components and Placebo
Condition: Hypertension
Interventions: Drug: Candesartan cilexetil;   Drug: Hydrochlorothiazide
15 Active, not recruiting DIabetic Retinopathy Candesartan Trials.
Condition: Type 1 Diabetes
Intervention: Drug: Candesartan Cilexetil
16 Recruiting Efficacy of Candesartan on Symptomatic Heart Failure in Treating Diabetic and Hypertensive Patients.
Condition: Heart Failure
Interventions: Drug: Candesartan and heart failure therapy with angiotensin-converting enzyme-inhibitors/beta-blockers.;   Drug: Heart failure therapy with angiotensin-converting enzyme-inhibitors/beta-blockers.
17 Not yet recruiting CCB Safety Study in Treatment of Hypertension of ADPKD
Condition: Kidney, Polycystic, Autosomal Dominant
Interventions: Drug: Candesartan;   Drug: Candesartan and Cilnidipine;   Drug: Candesartan plus non-CCB agents
18 Active, not recruiting Diabetic Retinopathy Candesartan Trials
Condition: Type 1 Diabetes
Intervention: Drug: candesartan cilexetil
19 Active, not recruiting DIabetic Retinopathy Candesartan Trials
Condition: Type 2 Diabetes
Intervention: Drug: Candesartan cilexetil
20 Recruiting Study to Demonstrate the Non-Inferiority of Olmesartan Medoxomil Versus Candesartan Cilexetil in Reducing Blood B-Type (or Brain) Natriuretic Peptide Levels at Week 24
Conditions: Chronic Heart Failure;   High Blood B-Type (or Brain) Natriuretic Peptide (BNP) Level
Interventions: Drug: olmesartan medoxomil + candesartan cilexetil placebo;   Drug: olmesartan medoxomil placebo + candesartan cilexetil

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services